Related Experiment Video
Updated: May 10, 2026
Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Published on: April 14, 2017
Investigating microcephaly
C Geoffrey Woods1, Alasdair Parker
1Department of Clinical Genetics, ATC, Addenbrooke's Hospital, Cambridge, UK. cw347@cam.ac.uk
Abstract:
1. Microcephaly is a clinical finding, not a 'disease', and is a crude but trusted assessment of intracranial brain volume. 2. Developmental processes reducing in utero neuron generation present at birth with 'Primary microcephaly'. 3. 'Secondary microcephaly' develops after birth and predominantly reflects dendritic or white matter diseases. 4. Microcephalic conditions have a heterogeneous aetiology, but increasingly genomic tests are available that allow an exact diagnosis.
Insights
Microcephaly, a brain size assessment, is not a disease but a clinical finding. Primary microcephaly stems from in utero developmental issues, while secondary microcephaly arises postnatally, often from white matter diseases, with genomic testing aiding diagnosis.
Area of Science:
- Neuroscience
- Genetics
- Pediatrics
Background:
- Microcephaly is a critical clinical finding, serving as an indicator of intracranial brain volume.
- It is essential to distinguish microcephaly as a sign, not an independent disease entity.
Purpose of the Study:
- To clarify the definition and classification of microcephaly.
- To highlight the etiological heterogeneity and diagnostic advancements in microcephalic conditions.
Main Methods:
- Clinical assessment and classification of microcephaly.
- Review of etiological factors, including developmental and postnatal causes.
- Evaluation of diagnostic tools, focusing on genomic testing.
Main Results:
- Microcephaly is defined as a clinical finding, not a disease, reflecting brain volume.
- Primary microcephaly results from impaired prenatal neuron generation.
- Secondary microcephaly is associated with postnatal conditions, particularly white matter diseases.
Conclusions:
- Microcephaly's heterogeneous origins necessitate precise diagnosis.
- Genomic testing offers an increasingly accurate method for diagnosing microcephalic conditions.
- Understanding the distinction between primary and secondary microcephaly is crucial for management.
More Related Videos
09:25Lineage Tracing and Clonal Analysis in Developing Cerebral Cortex Using Mosaic Analysis with Double Markers (MADM)
Published on: May 8, 2020
09:39Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
Published on: April 26, 2018